Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

'It sort of has the feel of being at home': Mixed-methods evaluation of a pilot community-based palliative end-of-life service in a regional setting.

The Australian journal of rural health·2022

Same author

Inpatient Dialysis Services: Nephrologist Leadership and Improving Quality and Safety.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2021

Same author

Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2021

Same author

Patterns of emergency department use in rural and metropolitan New South Wales from 2012 to 2018.

The Australian journal of rural health·2020

Same author

Retroperitoneal Sclerosing Lipogranuloma in an Adolescent With Congenital Atresia of the Inferior Vena Cava: Case Report and Literature Review.

Journal of pediatric hematology/oncology·2020

Same author

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2019

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Soft tissue sarcomas: current management and future directions.

Robert J Kenney¹, Richard Cheney, Margaret A Stull

¹Department of Surgery, University of Missouri-Kansas City, and Department of Diagnostic Radiology, St. Luke's Hospital of Kansas City, 2301 Holmes, Kansas City, MO 64108, USA.

The Surgical Clinics of North America

|February 3, 2009

Summary

This summary is machine-generated.

This review covers the latest in soft tissue sarcoma diagnosis and treatment, emphasizing surgical standards and future therapeutic directions for this rare cancer.

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Related Experiment Videos

Last Updated: Jun 26, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Area of Science:

Oncology
Surgical Oncology
Radiology

Background:

Soft tissue sarcomas are a heterogeneous group of malignant tumors.
Accurate diagnosis and staging are critical for effective management.
Treatment requires a multidisciplinary approach.

Purpose of the Study:

To provide an updated review of the diagnosis and treatment of soft tissue sarcomas.
To highlight current standards in surgical management.
To discuss future directions in sarcoma therapy.

Main Methods:

Comprehensive literature review of recent advancements.
Analysis of current diagnostic modalities including imaging and tissue sampling.
Evaluation of established and emerging treatment strategies.

Main Results:

Current diagnostic techniques ensure precise staging.
Surgical resection remains a cornerstone of treatment.
Multimodal therapy is often necessary for optimal outcomes.

Conclusions:

Adherence to current surgical standards improves patient outcomes.
Ongoing research is paving the way for novel therapeutic options.
Continued research is essential for advancing soft tissue sarcoma care.